# A Perspective Multicenter Controlled Study On Application Of Mesenchymal Stem Cell(MSC) To Prevent Rejection After Renal Transplantation By Donation After Cardiac Death

> **NCT02490020** · PHASE1 · UNKNOWN · sponsor: **Qipeng Sun** · enrollment: 260 (estimated)

## Conditions studied

- Disorder Related to Renal Transplantation
- Renal Transplant Rejection

## Interventions

- **BIOLOGICAL:** mesenchymal stem cell

## Key facts

- **NCT ID:** NCT02490020
- **Lead sponsor:** Qipeng Sun
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-01
- **Primary completion:** 2016-12
- **Final completion:** 2018-12
- **Target enrollment:** 260 (ESTIMATED)
- **Last updated:** 2015-07-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02490020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02490020, "A Perspective Multicenter Controlled Study On Application Of Mesenchymal Stem Cell(MSC) To Prevent Rejection After Renal Transplantation By Donation After Cardiac Death". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02490020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*